ENT1 (SLC29A1) is highly expressed in most types of cancers[5], where it carries out most of the facilitative uptake by tumor cells of natural nucleosides and nucleoside-derived drugs, such as gemcitabine or cytarabine[136,137]. Here, SLC29A1 is linked to neoplasm.